Cancer Survivor Stories

Challenging Paradigms: The Management of Rectal Cancer

One noteworthy case was a 78-year-old patient successfully treated without surgery.

Nagourney Cancer Institute: 20-year Experience in 10,000 Patients

At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.

Stage 4 Lung Cancer Patient Referred to Hospice: Rick Carroll

He has outlived cancer for over 16 years. To our knowledge one of the longest-living stage 4 cancer survivors from the armed forces.

Stage 4 Lung Cancer: Cheryl Scott

The results showed that all the drugs the other doctors recommended, paclitaxel, cisplatin, gemcitabine... would have been ineffective.

Non-Hodgkin's Lymphoma - Stage III: George Kalogridis

The information he received from the functional profile helped him find the right treatment regimen to save his life.

Stage 4 Stomach Cancer: Shelly Powell

My oncologist said that the results were remarkable and that I chose the right drugs based on Dr. Nagourney's testing.

Colon Cancer: Walt Wilson

Do your homework. Take charge of your care and don’t let anyone push you around. I took charge and I’m doing great 15 years later.

Stage 4 Breast Cancer Spread to Liver: Kathy Leach

After a review of the options, Dr. Nagourney explained that her highly favorable drug sensitivity profile suggested strong drug combonations

Ovarian Cancer - Stage III: Marcia Scheidler

Dr. Robert Nagourney was interviewed on the show “Extra”. He is having higher than normal results in treating cancer, with good outcomes.

Stage 4 Gastric Cancer of the Small Intestine: Jeff Ticehurst

The assay found that many of the standard chemotherapies would have been ineffective in killing Jeff’s cancer.

Stage 4 Pancreatic Cancer Spreadto Liver: Ken B

An endoscopic exam with biopsy confirmed that Ken had Stage 4 pancreatic cancer that had spread to his liver.

Mast Cell Sarcoma: Brittany Wnek

Within 11 days, Brittany's tryptase level went from high 100's, and over 200 in the end of October, to 24.